See up to 3 months of ALKS. The 7-day demo opens the 1M and 3M ranges and puts ALKS on your watchlist.
Start 7-day demoLatest ALKS insider trades
About Alkermes plc. (ALKS)
Alkermes plc. files with the SEC under CIK 0001520262 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ALKS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 76,150 | $3.75M |
| Grant or award | 4 | 242,771 | |
| Option exercise | 12 | 127,272 | |
ALKS insider transactions (Form 4)
4275 Form 4 filings on record, the earliest from Nov 6, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Option exercise | Ordinary Shares | 3,748 | $19.34 | $72K | ||
| Open-market sale | Ordinary Shares | 3,748 | $30.00 footnote F3 | $112K | ||
| Option exercise | Employee Stock Option (Right to Buy) | 3,748 | $0.00 | - | ||
| ||||||
| Open-market sale | Ordinary Shares | 4,000 | $29.30 | $117K | ||
| Option exercise | Ordinary Shares | 5,000 | $19.34 | $97K | ||
| Open-market sale | Ordinary Shares | 9,000 | $30.38 footnote F3 | $273K | ||
| Option exercise | Employee Stock Option (Right to Buy) | 5,000 | $0.00 | - | ||
| ||||||
| Option exercise | Ordinary Shares | 5,000 | $19.34 | $97K | ||
| Open-market sale | Ordinary Shares | 9,000 footnote F3 | $31.53 | $284K | ||
| Option exercise | Employee Stock Option (Right to Buy) | 5,000 | $0.00 | - | ||
| ||||||
| Joshua Reed - Officer | Grant or award | Employee Stock Option (Right to Buy) | 158,743 | $0.00 | - | |
| Joshua Reed - Officer | Grant or award | Restricted Stock Unit Award | 36,656 | $0.00 | - | |
| David Joseph Gaffin - Officer | Option exercise | Ordinary Shares | 2,014 | - | - | |
| David Joseph Gaffin - Officer | Tax withholding / forfeiture | Ordinary Shares | 895 | $26.55 | $24K | |
| David Joseph Gaffin - Officer | Option exercise | Restricted Stock Unit Award | 2,014 | - | - | |
| Brian P. McKeon - Director | Option exercise | Ordinary Shares | 8,013 | - | - | |
| Brian P. McKeon - Director | Tax withholding / forfeiture | Ordinary Shares | 1,924 | $30.61 | $59K | |
| Brian P. McKeon - Director | Option exercise | Restricted Stock Unit Award | 8,013 | - | - | |
| Brian P. McKeon - Director | Grant or award | Non Qualified Stock Option (Right to Buy) | 13,474 | $0.00 | - | |
| Brian P. McKeon - Director | Grant or award | Restricted Stock Unit Award | 6,142 | $0.00 | - | |
| Option exercise | Ordinary Shares | 12,452 | $20.03 | $249K | ||
| Option exercise | Ordinary Shares | 12,090 | $19.34 | $234K | ||
| Option exercise | Ordinary Shares | 12,044 | $24.59 | $296K | ||
| Option exercise | Ordinary Shares | 12,411 | $26.82 | $333K | ||
| Open-market sale | Ordinary Shares | 61,151 | $32.07 | $1.96M | ||
| Option exercise | Employee Stock Option (Right to Buy) | 12,452 | $0.00 | - | ||
| Option exercise | Employee Stock Option (Right to Buy) | 12,090 | $0.00 | - | ||
| Option exercise | Employee Stock Option (Right to Buy) | 12,044 | $0.00 | - | ||
| Option exercise | Employee Stock Option (Right to Buy) | 12,411 | $0.00 | - | ||
| Cato T. Laurencin - Director | Option exercise | Ordinary Shares | 4,163 | - | - | |
| Cato T. Laurencin - Director | Tax withholding / forfeiture | Ordinary Shares | 958 | $31.46 | $30K | |
| Cato T. Laurencin - Director | Option exercise | Ordinary Shares | 2,691 | $22.52 | $61K | |
| Cato T. Laurencin - Director | Open-market sale | Ordinary Shares | 2,691 | $31.85 | $86K | |
| Cato T. Laurencin - Director | Option exercise | Restricted Stock Unit Award | 4,163 | - | - | |
| Cato T. Laurencin - Director | Option exercise | Non Qualified Stock Option (Right to Buy) | 2,691 | $0.00 | - | |
| Open-market sale | Ordinary Shares | 9,221 | $31.50 | $290K | ||
| Open-market sale | Ordinary Shares | 14,349 | $30.77 | $442K | ||
| Christian Todd Nichols - Officer | Open-market sale | Ordinary Shares | 5,208 | $29.15 | $152K | |
| Option exercise | Ordinary Shares | 43,058 | $20.03 | $862K | ||
| Open-market sale | Ordinary Shares | 58,996 | $30.08 | $1.77M | ||
| Option exercise | Employee Stock Option (Right to Buy) | 43,058 | $0.00 | - | ||
| Open-market sale | Ordinary Shares | 10,471 | $29.53 | $309K | ||
Recent ALKS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Gaffin David Joseph | Officer | 2,034 | $83K | View on EDGAR | |
| Gaffin David Joseph | Officer | 2,034 |
Stock trades in ALKS disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
ALKS insider trading FAQ
What is the latest insider trade for ALKS?
Alkermes plc. (ALKS) had 10 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for ALKS runs to 75 Form 4 filings, the earliest from 2024-11-06. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALKS stock?
No insider purchases of ALKS were filed in the last 90 days.
How many insiders are selling ALKS stock?
8 insider sales of ALKS were filed in the last 90 days, totaling $3.75M.
Where can I see ALKS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALKS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joshua Reed view on EDGAR
- - Anne Clem Whitaker view on EDGAR
- - David Joseph Gaffin view on EDGAR
- - David Joseph Gaffin view on EDGAR
- - Craig C. Hopkinson view on EDGAR
- - Christian Todd Nichols view on EDGAR
- - Blair Curtis Jackson view on EDGAR
- - Nancy Lynn Md Snyderman view on EDGAR
- - Craig C. Hopkinson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ALKS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALKS with a 7-day demo
- ALKS on your watchlist
- Every ALKS Form 4 filing on record
- Up to 3 months of ALKS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive